American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6408)
  2. Solid Tumor Oncology Division (5546)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1381)
  9. Gastrointestinal Oncology Service (1356)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (79)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6408)
  2. Solid Tumor Oncology Division (5546)
  3. Survivorship Research (1999)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (308)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (303)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8712)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (12)

More Publications

Results (9195)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen
    Meeting Abstract

    Shen, S.; Myers, S.; Polidorio, N.; Bromberg, M.; Chen, Y.; Tan, R.; Mai, N.; Abuhadra, N.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Comparative analysis of PIK3CA mutation detection methods in the first-in-human phase 1/1b study of inavolisib
    Meeting Abstract

    Hilz, S.; Accordino, M. K.; Bedard, P.; Cervantes, A.; Gambardella, V.; Hamilton, E. P.; Italiano, A.; Jhaveri, K. L.; Juric, D.; Kalinsky, K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Opinions of real-world clinicians on endocrine resistance in HR+/HER2-mBC: Results from the RETRACT survey of US oncologists
    Meeting Abstract

    Gradishar, W. J.; Hamilton, E. P.; Mahtani, R. L.; Hurvitz, S. A.; Jhaveri, K. L.; Tolaney, S. M.; Rugo, H. S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Opinions of real-world clinicians regarding visceral crisis in HR+/HER2-mBC: Results from the RETRACT survey of US oncologists
    Meeting Abstract

    Jhaveri, K. L.; Gradishar, W. J.; Hamilton, E. P.; Hurvitz, S. A.; Mahtani, R. L.; Tolaney, S. M.; Rugo, H. S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Prediction of real-world progression free survival (rwPFS) using a multimodal machine learning (ML) model for patients with HR+HER2-metastatic breast cancer (mBC) undergoing first line (1L) treatment with cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) and endocrine therapy (ET)
    Meeting Abstract

    Razavi, P.; An, J. A. R.; Erazo, T.; Schwartz, P.; Ferrer, L.; Gallinato, O.; Papillon, L.; Colin, T.; Bossy, M.; Andre, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Improving adherence to cancer care for socioeconomically disadvantaged patients with central nervous system tumors
    Meeting Abstract

    Budhu, J. A.; Elshiekh, C.; Narang, B.; Rodriguez, A. M.; Phillips, A.; Gany, F.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Intrathecal deferoxamine in patients with leptomeningeal metastases: Phase 1a analysis
    Meeting Abstract

    Wilcox, J.; Reiner, A. S.; Young, R. J.; Emadi-Paramkouhi, L.; Weill, B.; Myers, L.; Tulca, Y.; Gonzalez, A.; Estrera, R.; Osei-Gyening, I.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Tumor-wide RNA splicing aberrations and their potential as therapeutic neoantigen targets
    Meeting Abstract

    Kwok, D.; Stevers, N.; Etxeberria, I.; Nejo, T.; Cove, M. C.; Chen, L.; Jung, J.; Okada, K.; Lakshmanachetty, S.; Gallus, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Genomic predictors of brain metastases in breast cancer
    Meeting Abstract

    Safonov, A.; Smith, D. R.; Nandakumar, S.; Ferraro, E.; Shen, J.; Khatri, I. S.; Kumar, R.; An, J. A. R.; Jee, J.; Robson, M. E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Magnetic resonance imaging (MRI) radiomics as predictor of clinical outcomes to neoadjuvant immunotherapy in patients with muscle invasive bladder cancer undergoing radical cystectomy
    Meeting Abstract

    Necchi, A.; Brembilla, G.; Arita, Y.; Akin, O.; Apte, A.; Cosenza, M.; Maiorano, B.; Tateo, V.; Cigliola, A.; Mercinelli, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save